A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Elidel Indications, Dosage, Storage, Stability - Pimecrolimus
Elidel Indications, Dosage, Storage, Stability - Pimecrolimus
INDICATIONS AND USAGE
Elidel® (pimecrolimus) Cream 1% is indicated
for short-term and intermittent long-term therapy in the treatment of mild
to moderate atopic dermatitis in non-immunocompromised patients 2 years
of age and older, in whom the use of alternative, conventional therapies is
deemed inadvisable because of potential risks, or in the treatment of patients
who are not adequately responsive to or intolerant of alternative, conventional
therapies (see DOSAGE AND ADMINISTRATION).
DOSAGE AND ADMINISTRATION
Apply a thin layer of Elidel® (pimecrolimus)
Cream 1% to the affected skin twice daily and rub in gently and completely.
Elidel may be used on all skin surfaces, including the head, neck, and intertriginous
areas.
Elidel should be used twice daily for as long as signs and
symptoms persist. Treatment should be discontinued if resolution of disease
occurs. If symptoms persist beyond 6 weeks, the patient should be re-evaluated.
The safety of Elidel Cream under occlusion, which may promote systemic exposure,
has not been evaluated. Elidel Cream should not be used with occlusive dressings.
HOW SUPPLIED
Elidel® (pimecrolimus) Cream 1% is available
in tubes of 15 grams, 30 grams, 60 grams, and 100 grams.
Elidel® (pimecrolimus) Cream 1% is available in tubes of 30 grams, 60 grams, and 100 grams.
30 gram tube - NDC 0078-0375-46
60 gram tube - NDC 0078-0375-49
100 gram tube - NDC 0078-0375-63
Store at 25°C (77°F); excursions permitted to 15°C-30°C (59°F-86°F). Do not freeze.
Manufactured by: Novartis Pharma GmbH, Wehr,
Germany, Distributed by: Novartis Pharmaceuticals Corp., East Hanover, NJ 07936,
REV. APRIL 2003, T2003-01 89014902 492573/1 US © Novartis
top
